CQW Panacea-re-brand-rev3

Pharmacy

For the Week of January 26, 2015

Question:

I just read your November 17, 2014, Q&A related to Medicare OPPS reimbursement for blood-clotting factors. Can you provide information related to inpatient payment?

Answer:

Blood-clotting factors administered to inpatients with hemophilia are eligible for separate Medicare payment under the inpatient PPS. Accordingly, if a beneficiary is in a covered Part A stay in a PPS hospital, Medicare reimburses the hospital for the blood-clotting factors in addition to the MS-DRG payment.

For more details about this coverage, go to Chapter 17, section 20, of the Medicare Claims Processing Manual http://www.cms.gov/Regulations-and-Guidance/Guidance/Manuals/Downloads/clm104c17.pdf.

Return to Compliance Question of the Week Index

BMQ3PRPHM4PT15

Sign up to receive Compliance Question of the Week.

To view and archive of the Pharmacy Compliance Question fo the Week, click here